IBDEI0N1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10254,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,10254,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,10255,0)
 ;;=J32.9^^74^673^4
 ;;^UTILITY(U,$J,358.3,10255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10255,1,3,0)
 ;;=3^Sinusitis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,10255,1,4,0)
 ;;=4^J32.9
 ;;^UTILITY(U,$J,358.3,10255,2)
 ;;=^5008207
 ;;^UTILITY(U,$J,358.3,10256,0)
 ;;=L03.211^^74^673^5
 ;;^UTILITY(U,$J,358.3,10256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10256,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,10256,1,4,0)
 ;;=4^L03.211
 ;;^UTILITY(U,$J,358.3,10256,2)
 ;;=^5009043
 ;;^UTILITY(U,$J,358.3,10257,0)
 ;;=H05.011^^74^673^6
 ;;^UTILITY(U,$J,358.3,10257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10257,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,10257,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,10257,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,10258,0)
 ;;=H05.012^^74^673^7
 ;;^UTILITY(U,$J,358.3,10258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10258,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,10258,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,10258,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,10259,0)
 ;;=L03.212^^74^673^9
 ;;^UTILITY(U,$J,358.3,10259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10259,1,3,0)
 ;;=3^Lymphangitis of Face,Acute
 ;;^UTILITY(U,$J,358.3,10259,1,4,0)
 ;;=4^L03.212
 ;;^UTILITY(U,$J,358.3,10259,2)
 ;;=^5009044
 ;;^UTILITY(U,$J,358.3,10260,0)
 ;;=Z90.01^^74^673^10
 ;;^UTILITY(U,$J,358.3,10260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10260,1,3,0)
 ;;=3^Acquired Absence of Eye
 ;;^UTILITY(U,$J,358.3,10260,1,4,0)
 ;;=4^Z90.01
 ;;^UTILITY(U,$J,358.3,10260,2)
 ;;=^322068
 ;;^UTILITY(U,$J,358.3,10261,0)
 ;;=H05.241^^74^673^13
 ;;^UTILITY(U,$J,358.3,10261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10261,1,3,0)
 ;;=3^Exophthalmos,Right Eye
 ;;^UTILITY(U,$J,358.3,10261,1,4,0)
 ;;=4^H05.241
 ;;^UTILITY(U,$J,358.3,10261,2)
 ;;=^5004598
 ;;^UTILITY(U,$J,358.3,10262,0)
 ;;=H05.242^^74^673^14
 ;;^UTILITY(U,$J,358.3,10262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10262,1,3,0)
 ;;=3^Exophthalmos,Left Eye
 ;;^UTILITY(U,$J,358.3,10262,1,4,0)
 ;;=4^H05.242
 ;;^UTILITY(U,$J,358.3,10262,2)
 ;;=^5004599
 ;;^UTILITY(U,$J,358.3,10263,0)
 ;;=H44.521^^74^673^15
 ;;^UTILITY(U,$J,358.3,10263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10263,1,3,0)
 ;;=3^Atrophy of Globe,Right Eye
 ;;^UTILITY(U,$J,358.3,10263,1,4,0)
 ;;=4^H44.521
 ;;^UTILITY(U,$J,358.3,10263,2)
 ;;=^5006025
 ;;^UTILITY(U,$J,358.3,10264,0)
 ;;=H44.522^^74^673^16
 ;;^UTILITY(U,$J,358.3,10264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10264,1,3,0)
 ;;=3^Atrophy of Globe,Left Eye
 ;;^UTILITY(U,$J,358.3,10264,1,4,0)
 ;;=4^H44.522
 ;;^UTILITY(U,$J,358.3,10264,2)
 ;;=^5006026
 ;;^UTILITY(U,$J,358.3,10265,0)
 ;;=T85.79XA^^74^673^19
 ;;^UTILITY(U,$J,358.3,10265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10265,1,3,0)
 ;;=3^Infect/Inflm Reaction d/t Internal Prosthetic Device/Implant,Init Encntr
 ;;^UTILITY(U,$J,358.3,10265,1,4,0)
 ;;=4^T85.79XA
 ;;^UTILITY(U,$J,358.3,10265,2)
 ;;=^5055676
 ;;^UTILITY(U,$J,358.3,10266,0)
 ;;=T85.398A^^74^673^20
 ;;^UTILITY(U,$J,358.3,10266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10266,1,3,0)
 ;;=3^Mech Compl of Ocular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,10266,1,4,0)
 ;;=4^T85.398A
 ;;^UTILITY(U,$J,358.3,10266,2)
 ;;=^5055559
